Why KaloCyte picked Baltimore and the BioPark

The University of Maryland BioPark and proximity to key stakeholders were two of the top reasons KaloCyte decided to move to Baltimore, its CEO said. The company that is developing an artificial red blood cell moved to Baltimore from St. Louis last month. “While we benefited greatly from our roots at St. Louis … as we started ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.